Immunodeficiency disorders and autoimmune diseases are common, but a lack of effective targeted drugs and the side-effects of existing drugs have stimulated interest in finding therapeutic alternatives. Naturally derived substances are a recognized source of novel drugs, and tick saliva is increasingly recognized as a rich source of bioactive molecules with specific functions. Ticks use their saliva to overcome the innate and adaptive host immune systems. Their saliva is a rich cocktail of molecules including proteins, peptides, lipid derivatives, and recently discovered non-coding RNAs that inhibit or modulate vertebrate immune reactions. A number of tick saliva and/or salivary gland molecules have been characterized and shown to be promising candidates for drug development for vertebrate immune diseases. However, further validation of these molecules at the molecular, cellular, and organism levels is now required to progress lead candidates to clinical testing. In this paper, we review the data on the immuno-pharmacological aspects of tick salivary compounds characterized in vitro and/or in vivo and present recent findings on non-coding RNAs that might be exploitable as immunomodulatory therapies.

Department of Medical Biology Faculty of Science University of South Bohemia in České Budějovice České Budějovice Czechia

Innovation and Development Laboratory Innovation and Development Center Instituto Butantan São Paulo Brazil

Institut Pasteur de Tunis LR19IPTX Service d'Entomologie Médicale Université de Tunis El Manar Tunis Tunisia

Institute of Parasitology Biology Centre Czech Academy of Sciences České Budějovice Czechia

Zobrazit více v PubMed

Raje N, Dinakar C. Overview of immunodeficiency disorders. PubMed DOI PMC

Wang L, Wang FS, Gershwin ME. Human autoimmune diseases: a comprehensive update. PubMed DOI

Bogdanos DP, Smyk DS, Rigopoulou EI, Mytilinaiou MG, Heneghan MA, Selmi C, et al. Twin studies in autoimmune disease: genetics, gender and environment. PubMed DOI

Mahoney EJ, Veling MC, Mims JW. Food allergy in adults and children. PubMed DOI

Peden DB. Effect of pollution on allergy/immunology. PubMed DOI

Nikolich-Žugich J. The twilight of immunity: emerging concepts in aging of the immune system. PubMed DOI

Krones E, Högenauer C. Diarrhea in the immunocompromised patient. PubMed DOI

Girish MB. Emerging drugs for the treatment of human immunodeficiency virus. PubMed DOI

Bucktrout SL, Bluestone JA, Ramsdell F. Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again. PubMed DOI PMC

Li G, Lou H-X. Strategies to diversify natural products for drug discovery. PubMed DOI

Lautié E, Russo O, Ducrot P, Boutin JA. Unraveling plant natural chemical diversity for drug discovery purposes. PubMed DOI PMC

Uzair B, Bint-e-Irshad S, Khan BA, Azad B, Mahmood T, Rehman MU, et al. Scorpion venom peptides as a potential source for human drug candidates. PubMed DOI

Perumal Samy R, Stiles BG, Franco OL, Sethi G, Lim LHK. Animal venoms as antimicrobial agents. PubMed DOI

Franchin M, Freires IA, Lazarini JG, Nani BD, da Cunha MG, Colón DF, et al. The use of Brazilian propolis for discovery and development of novel anti-inflammatory drugs. PubMed DOI

Katz L, Baltz RH. Natural product discovery: past, present, and future. PubMed DOI

Gileadi O. Recombinant protein expression in PubMed DOI

Baghban R, Farajnia S, Ghasemi Y, Mortazavi M, Zarghami N, Samadi N. New developments in PubMed DOI

Rozov SM, Permyakova NV, Deineko EV. Main strategies of plant expression system glycoengineering for producing humanized recombinant pharmaceutical proteins. PubMed DOI

Metzker ML. Sequencing technologies the next generation. PubMed DOI

Wingfield J, Wilson ID. Advances in mass spectrometry within drug discovery. PubMed DOI

Chmelar J, Kotál J, Kovaríková A, Kotsyfakis M. The use of tick salivary proteins as novel therapeutics. PubMed DOI PMC

Francischetti IMB, Sa-Nunes A, Mans BJ, Santos IM, Ribeiro JMC. The role of saliva in tick feeding. PubMed DOI PMC

Chmelar J, Calvo E, Pedra JHF, Francischetti IMB, Kotsyfakis M. Tick salivary secretion as a source of antihemostatics. PubMed DOI PMC

Boulanger N. [Immunomodulatory effect of tick saliva in pathogen transmission]. PubMed DOI

Maria DA, Will SEAL, Bosch RV, Souza JG, Sciani JM, Goldfeder MB, et al. Preclinical evaluation of Amblyomin-X, a Kunitz-type protease inhibitor with antitumor activity. PubMed DOI PMC

Boufleur P, Sciani JM, Goldfeder M, Faria F, Branco V, Chudzinski-Tavassi AM. Biodistribution and pharmacokinetics of Amblyomin-X, a novel antitumour protein drug in healthy mice. PubMed DOI

Jongejan F, Uilenberg G. The global importance of ticks. PubMed DOI

Sonenshine DE. Biology of ticks. PubMed DOI

Nuttall PA. Wonders of tick saliva. PubMed DOI

Castelli E, Caputo V, Morello V, Tomasino RM. Local reactions to tick bites. PubMed DOI

Bernard Q, Grillon A, Lenormand C, Ehret-Sabatier L, Boulanger N. Skin interface, a key player for PubMed DOI

Hermance ME, Thangamani S. Tick–virus–host interactions at the cutaneous interface: the nidus of flavivirus transmission. PubMed DOI PMC

Kazimírová M, Štibrániová I. Tick salivary compounds: their role in modulation of host defences and pathogen transmission. PubMed DOI PMC

Versteeg HH, Heemskerk JWM, Levi M, Reitsma PH. New fundamentals in hemostasis. PubMed DOI

Chudzinski-Tavassi AM, Faria F, Flores MPA. Anticoagulants from hematophagous. In: Mijovski MB. editor. DOI

Carroll MC, Isenman DE. Regulation of humoral immunity by complement. PubMed DOI PMC

Dunkelberger JR, Song WC. Complement and its role in innate and adaptive immune responses. PubMed DOI

Wikel S. Ticks and tick-borne pathogens at the cutaneous interface: host defenses, tick countermeasures, and a suitable environment for pathogen establishment. PubMed DOI PMC

Glatz M, Means T, Haas J, Steere AC, Müllegger RR. Characterization of the early local immune response to PubMed DOI PMC

Buczek A, Bartosik K. [Tick-host interactions]. PubMed

Krause PJ, Grant-Kels JM, Tahan SR, Dardick KR, Alarcon-Chaidez F, Bouchard K, et al. Dermatologic changes induced by repeated PubMed DOI PMC

Kiripolsky J, McCabe LG, Kramer JM. Innate immunity in Sjögren’s syndrome. PubMed DOI PMC

Cepika AM, Sato Y, Liu JMH, Uyeda MJ, Bacchetta R, Roncarolo MG. Tregopathies: monogenic diseases resulting in regulatory T-cell deficiency. PubMed DOI

Anderton SM. Peptide immunotherapy in experimental autoimmune encephalomyelitis. PubMed DOI

Morgan BP, Harris CL. Complement, a target for therapy in inflammatory and degenerative diseases. PubMed DOI PMC

Anguita J, Ramamoorthi N, Hovius JWR, Das S, Thomas V, Persinski R, et al. Salp15, an PubMed DOI

Wen S, Wang F, Ji Z, Pan Y, Jian M, Bi Y, et al. Salp15, a multifunctional protein from tick saliva with potential pharmaceutical effects. PubMed DOI PMC

Yang T, Sui X, Yu B, Shen Y, Cong H. Recent advances in the rational drug design based on multi-target ligands. PubMed DOI

Kumar A, Tiwari A, Sharma A. Changing paradigm from one target one ligand towards multi-target directed ligand design for key drug targets of alzheimer disease: an important role of PubMed DOI PMC

Talevi A. Multi-target pharmacology: possibilities and limitations of the “skeleton key approach” from a medicinal chemist perspective. PubMed DOI PMC

Talevi A. Tailored multi-target agents. applications and design considerations. PubMed DOI

Kotál J, Langhansová H, Lieskovská J, Andersen JF, Francischetti IMB, Chavakis T, et al. Modulation of host immunity by tick saliva. PubMed DOI PMC

Almazan C, Tipacamu GA, Rodriguez S, Mosqueda J, Perez de Leon A. Immunological control of ticks and tick-borne diseases that impact cattle health and production. PubMed DOI

Šimo L, Kazimirova M, Richardson J, Bonnet SI. The essential role of tick salivary glands and saliva in tick feeding and pathogen transmission. PubMed DOI PMC

Štibrániová I, Bartíková P, Holíková V, Kazimírová M. Deciphering biological processes at the tick-host interface opens new strategies for treatment of human diseases. PubMed DOI PMC

Schmidt MCB, Morais KLP, Almeida MES, Iqbal A, Goldfeder MB, Chudzinski-Tavassi AM. Amblyomin-X, a recombinant Kunitz-type inhibitor, regulates cell adhesion and migration of human tumor cells. PubMed DOI PMC

Lichtenstein F, Iqbal A, de Lima Will SEA, Bosch RV, DeOcesano-Pereira C, Goldfeder MB, et al. Modulation of stress and immune response by Amblyomin-X results in tumor cell death in a horse melanoma model. PubMed DOI PMC

Pireaux V, Tassignon J, Demoulin S, Derochette S, Borenstein N, Ente A, et al. Anticoagulation with an inhibitor of factors XIa and XIIa during cardiopulmonary bypass. PubMed DOI

Yeh CH, Fredenburgh JC, Weitz JI. Oral direct factor Xa inhibitors. PubMed DOI

Borriello F, Iannone R, Marone G. Histamine release from mast cells and basophils. In: Hattori Y, Seifert R. editors PubMed DOI

Coutinho ML, Bizzarro B, Tirloni L, Berger M, Freire Oliveira CJ, Sá-Nunes A, et al. PubMed DOI PMC

Paesen GC, Adams PL, Harlos K, Nuttall PA, Stuart DI. Tick histamine-binding proteins: isolation, cloning, and three-dimensional structure. PubMed DOI

Paesen GC, Adams PL, Nuttall PA, Stuart DL. Tick histamine-binding proteins: lipocalins with a second binding cavity. PubMed DOI

Wang Y, Li Z, Zhou Y, Cao J, Zhang H, Gong H, et al. Specific histamine binding activity of a new lipocalin from PubMed DOI PMC

Sangamnatdej S, Paesen GC, Slovak M, Nuttall PA. A high affinity serotonin- and histamine-binding lipocalin from tick saliva. PubMed DOI

Mohajeri M, Kovanen PT, Bianconi V, Pirro M, Cicero AFG, Sahebkar A. Mast cell tryptase – marker and maker of cardiovascular diseases. PubMed DOI

Ni WW, Da Cao M, Huang W, Meng L, Wei JF. Tryptase inhibitors: a patent review. PubMed DOI

Paesen GC, Siebold C, Harlos K, Peacey MF, Nuttall PA, Stuart DIA. Tick protein with a modified kunitz fold inhibits human tryptase. PubMed DOI

Valdés JJ, Schwarz A, Cabeza de Vaca I, Calvo E, Pedra JHF, Guallar V, et al. Tryptogalinin is a tick kunitz serine protease inhibitor with a unique intrinsic disorder. PubMed DOI PMC

Sommerhoff C, Schaschke N. Mast cell tryptase β as a target in allergic inflammation: an evolving story. PubMed DOI

Andrade BB, Teixeira CR, Barral A, Barral-Netto M. Haematophagous arthropod saliva and host defense system: a tale of tear and blood. PubMed DOI

Jaworski DC, Jasinskas A, Metz CN, Bucala R, Barbour AG. Identification and characterization of a homologue of the pro-inflammatory cytokine macrophage migration inhibitory factor in the tick, PubMed DOI

Bowen CJ, Jaworski DC, Wasala NB, Coons LB. Macrophage migration inhibitory factor expression and protein localization in PubMed DOI

Umemiya R, Hatta T, Liao M, Tanaka M, Zhou J, Inoue N, et al. PubMed DOI

Beaufays J, Adam B, Menten-Dedoyart C, Fievez L, Grosjean A, Decrem Y, et al. Ir-LBP, an PubMed DOI PMC

Hidano A, Konnai S, Yamada S, Githaka N, Isezaki M, Higuchi H, et al. Suppressive effects of neutrophil by Salp16-like salivary gland proteins from PubMed DOI

Bhusal RP, Eaton JRO, Chowdhury ST, Power CA, Proudfoot AEI, Stone MJ, et al. Evasins: tick salivary proteins that inhibit mammalian chemokines. PubMed DOI PMC

Frauenschuh A, Power CA, Déruaz M, Ferreira BR, Silva JS, Teixeira MM, et al. Molecular cloning and characterization of a highly selective chemokine-binding protein from the tick Rhipicephalus sanguineus. PubMed DOI

Russo RC, Alessandri AL, Garcia CC, Cordeiro BF, Pinho V, Cassali GD, et al. Therapeutic effects of evasin-1, a chemokine binding protein, in bleomycin-induced pulmonary fibrosis. PubMed DOI

Castor MGM, Rezende B, Resende CB, Alessandri AL, Fagundes CT, Sousa LP, et al. The CCL3/Macrophage inflammatory protein-1a-binding protein evasin-1 protects from graft-versus-host disease but does not modify graft-versus-leukemia in mice. PubMed DOI

Déruaz M, Frauenschuh A, Alessandri AL, Dias JM, Coelho FM, Russo RC, et al. Ticks produce highly selective chemokine binding proteins with antiinflammatory activity. PubMed DOI PMC

Denisov SS, Ippel JH, Heinzmann ACA, Koenen RR, Ortega-Gomez A, Soehnlein O, et al. Tick saliva protein Evasin-3 modulates chemotaxis by disrupting CXCL8 interactions with glycosaminoglycans and CXCR2. PubMed DOI PMC

Montecucco F, Lenglet S, Braunersreuther V, Pelli G, Pellieux C, Montessuit C, et al. Single administration of the CXC chemokine-binding protein evasin-3 during ischemia prevents myocardial reperfusion injury in mice. PubMed DOI

Copin JC, Da Silva RF, Fraga-Silva RA, Capettini L, Quintao S, Lenglet S, et al. Treatment with Evasin-3 reduces atherosclerotic vulnerability for ischemic stroke, but not brain injury in mice. PubMed DOI PMC

Montecucco F, Mach F, Lenglet S, Vonlaufen A, Gomes Quinderé AL, Pelli G, et al. Treatment with Evasin-3 abrogates neutrophil-mediated inflammation in mouse acute pancreatitis. PubMed DOI

Braunersreuther V, Montecucco F, Pelli G, Galan K, Proudfoot AE, Belin A, et al. Treatment with the CC chemokine-binding protein Evasin-4 improves post-infarction myocardial injury and survival in mice. PubMed DOI

Darlot B, Eaton JRO, Geis-Asteggiante L, Yakala GK, Karuppanan K, Davies G, et al. Engineered anti-inflammatory peptides inspired by mapping an evasin-chemokine interaction. PubMed DOI PMC

Wu J, Wang Y, Liu H, Yang H, Ma D, Li J, et al. Two immunoregulatory peptides with antioxidant activity from tick salivary glands. PubMed DOI PMC

Tian Y, Chen W, Mo G, Chen R, Fang M, Yedid G, et al. An immunosuppressant peptide from the hard tick PubMed DOI PMC

Wang F, Gong H, Zhang H, Zhou Y, Cao J, Zhou J. Lipopolysaccharide-induced differential expression of mirnas in male and female PubMed DOI PMC

Kim TK, Tirloni L, Berger M, Diedrich JK, Yates JR, Termignoni C, et al. PubMed DOI PMC

Tirloni L, Kim TK, Berger M, Termignoni C, Da Silva Vaz I, Mulenga A. PubMed DOI PMC

Chmelar J, Oliveira CJ, Rezacova P, Francischetti IMB, Kovarova Z, Pejler G, et al. A tick salivary protein targets cathepsin G and chymase and inhibits host inflammation and platelet aggregation. PubMed DOI PMC

Páleníková J, Lieskovská J, Langhansová H, Kotsyfakis M, Chmelaø J, Kopeck? J. PubMed DOI PMC

Sun T, Wang F, Pan W, Wu Q, Wang J, Dai J. An immunosuppressive tick salivary gland protein DsCystatin interferes with toll-like receptor signaling by downregulating TRAF6. PubMed DOI PMC

Dickinson RG, O’Hagan JE, Schotz M, Binnington KC, Hegarty MP. Prostaglandin in the saliva of the cattle tick PubMed DOI

Ruan D, So S-P. Prostaglandin E2 produced by inducible COX-2 and mPGES-1 promoting cancer cell proliferation PubMed DOI

Fezza F, Dillwith JW, Bisogno T, Tucker JS, Di Marzo V, Sauer JR. Endocannabinoids and related fatty acid amides, and their regulation, in the salivary glands of the lone star tick. PubMed DOI

Oliveira CJF, Sá-Nunes A, Francischetti IMB, Carregaro V, Anatriello E, Silva JS, et al. Deconstructing tick saliva: non-protein molecules with potent immunomodulatory properties. PubMed DOI PMC

Della Latta V, Cabiati M, Rocchiccioli S, Del Ry S, Morales MA. The role of the adenosinergic system in lung fibrosis. PubMed DOI

Jarvis MF. Therapeutic potential of adenosine kinase inhibition–revisited. PubMed DOI PMC

Cai Y, Feng L, Wang X. Targeting the tumor promoting effects of adenosine in chronic lymphocytic leukemia. PubMed DOI

Honda T, Matsuoka T, Ueta M, Kabashima K, Miyachi Y, Narumiya S. Prostaglandin E2-EP3 signaling suppresses skin inflammation in murine contact hypersensitivity. PubMed DOI

Nakanishi M, Rosenberg DW. Multifaceted roles of PGE2 in inflammation and cancer. PubMed DOI PMC

Łukawska E, Polcyn-Adamczak M, Niemir ZI. The role of the alternative pathway of complement activation in glomerular diseases. PubMed DOI

Thorgersen EB, Barratt-Due A, Haugaa H, Harboe M, Pischke SE, Nilsson PH, et al. The role of complement in liver injury, regeneration, and transplantation. PubMed DOI PMC

Tichaczek-Goska D. Deficiencies and excessive human complement system activation in disorders of multifarious etiology. PubMed

Ricklin D, Reis ES, Lambris JD. Complement in disease: a defence system turning offensive. PubMed DOI PMC

Ricklin D, Mastellos DC, Reis ES, Lambris JD. The renaissance of complement therapeutics. PubMed DOI PMC

Valenzuela JG, Charlab R, Mather TN, Ribeiro JMC. Purification, cloning, and expression of a novel salivary anticomplement protein from the tick PubMed DOI

Schroeder H, Daix V, Gillet L, Renauld JC, Vanderplasschen A. The paralogous salivary anti-complement proteins IRAC I and IRAC II encoded by PubMed DOI

Zwarthoff SA, Berends ETM, Mol S, Ruyken M, Aerts PC, Józsi M, et al. Functional characterization of alternative and classical pathway C3/C5 convertase activity and inhibition using purified models. PubMed DOI PMC

Hourcade DE, Akk AM, Mitchell LM, Zhou HF, Hauhart R, Pham CTN. Anti-complement activity of the PubMed DOI PMC

Couvreur B, Beaufays J, Charon C, Lahaye K, Gensale F, Denis V, et al. Variability and action mechanism of a family of anticomplement proteins in PubMed DOI PMC

Barratt-Due A, Thorgersen EB, Lindstad JK, Pharo A, Lissina O, Lambris JD, et al. PubMed DOI PMC

Nunn MA, Sharma A, Paesen GC, Adamson S, Lissina O, Willis AC, et al. Complement inhibitor of C5 activation from the soft tick PubMed DOI

Mans BJ, Ribeiro JMC. Function, mechanism and evolution of the moubatin-clade of soft tick lipocalins. PubMed DOI PMC

Hepburn NJ, Williams AS, Nunn MA, Chamberlain-Banoub JC, Hamer J, Morgan BP, et al. PubMed DOI

Kuhn N, Schmidt CQ, Schlapschy M, Skerra A. PASylated coversin, a C5-specific complement inhibitor with extended pharmacokinetics, shows enhanced anti-hemolytic activity PubMed DOI

Barratt-Due A, Thorgersen EB, Egge K, Pischke S, Sokolov A, Hellerud BC, et al. Combined inhibition of complement (C5) and CD14 markedly attenuates inflammation, thrombogenicity, and hemodynamic changes in porcine sepsis. PubMed DOI

Jore MM, Johnson S, Sheppard D, Barber NM, Li YI, Nunn MA, et al. Structural basis for therapeutic inhibition of complement C5. PubMed DOI PMC

Reichhardt MP, Johnson S, Tang T, Morgan T, Tebeka N, Popitsch N, et al. An inhibitor of complement C5 provides structural insights into activation. PubMed DOI PMC

Yuan X, Gavriilaki E, Thanassi JA, Yang G, Baines AC, Podos SD, et al. Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. PubMed DOI PMC

Rother RP, Rollins SA, Mojcik CF, Brodsky RA, Bell L. Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria. PubMed DOI

Schuijt TJ, Coumou J, Narasimhan S, Dai J, Deponte K, Wouters D, et al. A tick mannose-binding lectin inhibitor interferes with the vertebrate complement cascade to enhance transmission of the lyme disease agent. PubMed DOI PMC

Dommett RM, Klein N, Turner MW. Mannose-binding lectin in innate immunity: past, present and future. PubMed DOI PMC

Wagemakers A, Coumou J, Schuijt TJ, Oei A, Nijhof AM, van ’t Veer C, et al. An PubMed DOI

Coumou J, Wagemakers A, Narasimhan S, Schuijt TJ, Ersoz JI, Oei A, et al. The role of mannose binding lectin in the immune response against PubMed DOI PMC

Kaźmierczak-Siedlecka K, Dvor̆ák A, Folwarski M, Daca A, Przewłócka K, Makarewicz W. Fungal gut microbiota dysbiosis and its role in colorectal, oral, and pancreatic carcinogenesis. PubMed DOI PMC

Sá-Nunes A, Bafica A, Lucas DA, Conrads TP, Veenstra TD, Andersen JF, et al. Prostaglandin E PubMed DOI

Esteves E, Bizzarro B, Costa FB, Ramírez-Hernández A, Peti APF, Cataneo AHD, et al. Amblyomma sculptum salivary PGE 2 modulates the dendritic cell PubMed DOI PMC

Xu Z, Lin Z, Wei N, Di Q, Cao J, Zhou Y, et al. Immunomodulatory effects of PubMed DOI PMC

Preston SG, Majtán J, Kouremenou C, Rysnik O, Burger LF, Cabezas Cruz A, et al. Novel immunomodulators from hard ticks selectively reprogramme human dendritic cell responses. PubMed DOI PMC

Hannier S, Liversidge J, Sternberg JM, Bowman AS. PubMed DOI

Hannier S, Liversidge J, Sternberg JM, Bowman AS. Characterization of the B-cell inhibitory protein factor in PubMed DOI PMC

Yu D, Liang J, Yu H, Wu H, Xu C, Liu J, et al. A tick B-cell inhibitory protein from salivary glands of the hard tick, PubMed DOI

Dk B, Mj P, Mj C, Jd R, Sk W. Isolation and molecular cloning of a secreted immunosuppressant protein from PubMed

Alarcon-Chaidez FJ, Müller-Doblies UU, Wikel S. Characterization of a recombinant immunomodulatory protein from the salivary glands of PubMed DOI

Konnai S, Nakajima C, Imamura S, Yamada S, Nishikado H, Kodama M, et al. Suppression of cell proliferation and cytokine expression by HL-p36, a tick salivary gland-derived protein of PubMed DOI PMC

Wang F, Lu X, Guo F, Gong H, Zhang H, Zhou Y, et al. The immunomodulatory protein RH36 is relating to blood-feeding success and oviposition in hard ticks. PubMed DOI

Kotsyfakis M, Horka H, Salat J, Andersen JF. The crystal structures of two salivary cystatins from the tick PubMed DOI PMC

Kotsyfakis M, Sá-Nunes A, Francischetti IMB, Mather TN, Andersen JF, Ribeiro JMC. Antiinflammatory and immunosuppressive activity of sialostatin L, a salivary cystatin from the tick PubMed DOI

Horka H, Staudt V, Klein M, Taube C, Reuter S, Dehzad N, et al. The tick salivary protein Sialostatin L Inhibits the Th9-derived production of the asthma-promoting cytokine il-9 and is effective in the prevention of experimental asthma. PubMed DOI PMC

Sá-Nunes A, Bafica A, Antonelli LR, Choi EY, Francischetti IMB, Andersen JF, et al. The immunomodulatory action of Sialostatin L on dendritic cells reveals its potential to interfere with autoimmunity. PubMed DOI PMC

Lieskovská J, Páleníková J, Širmarová J, Elsterová J, Kotsyfakis M, Campos Chagas A, et al. Tick salivary cystatin sialostatin L2 suppresses IFN responses in mouse dendritic cells. PubMed DOI

Chen G, Wang X, Severo MS, Sakhon OS, Sohail M, Brown LJ, et al. The tick salivary protein sialostatin L2 inhibits caspase-1-mediated inflammation during PubMed DOI PMC

Kotál J, Stergiou N, Buša M, Chlastáková A, Beránková Z, R̆ezáčová P, et al. The structure and function of Iristatin, a novel immunosuppressive tick salivary cystatin. PubMed DOI PMC

Leboulle G, Crippa M, Decrem Y, Mejri N, Brossard M, Bollen A, et al. Characterization of a novel salivary immunosuppressive protein from PubMed DOI

Toyomane K, Konnai S, Niwa A, Githaka N, Isezaki M, Yamada S, et al. Identification and the preliminary PubMed DOI

Prevot PP, Beschin A, Lins L, Beaufays J, Grosjean A, Bruys L, et al. Exosites mediate the anti-inflammatory effects of a multifunctional serpin from the saliva of the tick PubMed DOI

Blisnick AA, Šimo L, Grillon C, Fasani F, Brûlé S, Le Bonniec B, et al. The immunomodulatory effect of IrSPI, a tick salivary gland serine protease inhibitor involved in PubMed DOI PMC

Garg R, Juncadella IJ, Ramamoorthi N, Ashish, Ananthanarayanan SK, Thomas V, et al. Cutting edge: CD4 is the receptor for the tick saliva immunosuppressor, Salp15. PubMed DOI PMC

Marchal C, Schramm F, Kern A, Luft BJ, Yang X, Schuijt TJ, et al. Antialarmin effect of tick saliva during the transmission of Lyme disease. PubMed DOI PMC

Paveglio SA, Allard J, Mayette J, Whittaker LA, Juncadella I, Anguita J, et al. The tick salivary protein, Salp15, inhibits the development of experimental asthma. PubMed DOI PMC

Juncadella IJ, Garg R, Bates TC, Olivera ER, Anguita J. The PubMed DOI PMC

Liu Q, Acharya P, Dolan MA, Zhang P, Guzzo C, Lu J, et al. Quaternary contact in the initial interaction of CD4 with the HIV-1 envelope trimer. PubMed DOI PMC

Juncadella IJ, Bates TC, Suleiman R, Monteagudo-Mera A, Olson CM, Navasa N, et al. The tick saliva immunosuppressor, Salp15, contributes to Th17-induced pathology during experimental autoimmune encephalomyelitis. PubMed DOI PMC

Robinson AP, Harp CT, Noronha A, Miller SD. The experimental autoimmune encephalomyelitis (EAE) model of MS. utility for understanding disease pathophysiology and treatment. PubMed DOI PMC

Tomás-Cortázar J, Martín-Ruiz I, Barriales D, Pascual-Itoiz MÁ, de Juan VG, Caro-Maldonado A, et al. The immunosuppressive effect of the tick protein, Salp15, is long-lasting and persists in a murine model of hematopoietic transplant. PubMed DOI PMC

Chmelar̆ J, Kotál J, Karim S, Kopacek P, Francischetti IMB, Pedra JHF, et al. Sialomes and mialomes: a systems-biology view of tick tissues and tick-host interactions. PubMed DOI PMC

Lefebvre FA, Lécuyer E. Small luggage for a long journey: transfer of vesicle-enclosed small RNA in interspecies communication. PubMed DOI PMC

Knip M, Constantin ME, Thordal-Christensen H. Trans-kingdom cross-talk: small RNAs on the move. PubMed DOI PMC

Weiberg A, Bellinger M, Jin H. Conversations between kingdoms: small RNAs. PubMed DOI PMC

Barrero RA, Keeble-Gagnère G, Zhang B, Moolhuijzen P, Ikeo K, Tateno Y, et al. Evolutionary conserved microRNAs are ubiquitously expressed compared to tick-specific miRNAs in the cattle tick PubMed DOI PMC

Bensaoud C, Hackenberg M, Kotsyfakis M. Noncoding RNAs in parasite–vector–host interactions. PubMed DOI

Chávez ASO, O’Neal AJ, Santambrogio L, Kotsyfakis M, Pedra JHF. Message in a vesicle – trans-kingdom intercommunication at the vector-host interface. PubMed DOI PMC

Hackenberg M, Kotsyfakis M. Exosome-mediated pathogen transmission by arthropod vectors. PubMed DOI

Yao R-W, Wang Y, Chen L-L. Cellular functions of long noncoding RNAs. PubMed DOI

Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. PubMed DOI

Gomes AQ, Nolasco S, Soares H. Non-coding RNAs: multi-tasking molecules in the cell. PubMed DOI PMC

Hackenberg M, Langenberger D, Schwarz A, Erhart J, Kotsyfakis M. PubMed DOI PMC

Christopher AF, Kaur RP, Kaur G, Kaur A, Gupta V, Bansal P. MicroRNA therapeutics: discovering novel targets and developing specific therapy. PubMed DOI PMC

Bulk and single-nucleus RNA sequencing highlight immune pathways induced in individuals during an Ixodes scapularis tick bite

Protease-bound structure of Ricistatin provides insights into the mechanism of action of tick salivary cystatins in the vertebrate host

Iripin-1, a new anti-inflammatory tick serpin, inhibits leukocyte recruitment in vivo while altering the levels of chemokines and adhesion molecules

Transcriptomic analysis of the tick midgut and salivary gland responses upon repeated blood-feeding on a vertebrate host

Serpins in Tick Physiology and Tick-Host Interaction

Insights into the Role of Tick Salivary Protease Inhibitors during Ectoparasite-Host Crosstalk

Long Non-Coding RNAs and Their Potential Roles in the Vector-Host-Pathogen Triad